ImmunityBio (STU:26CA) Days Sales Outstanding : 0.00 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Days Sales Outstanding?

ImmunityBio's average Accounts Receivable for the three months ended in Mar. 2024 was €0.00 Mil. ImmunityBio's Revenue for the three months ended in Mar. 2024 was €0.04 Mil. Hence, ImmunityBio's Days Sales Outstanding for the three months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for ImmunityBio's Days Sales Outstanding or its related term are showing as below:

STU:26CA's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.43
* Ranked among companies with meaningful Days Sales Outstanding only.

ImmunityBio's Days Sales Outstanding stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

ImmunityBio Days Sales Outstanding Historical Data

The historical data trend for ImmunityBio's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Days Sales Outstanding Chart

ImmunityBio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

ImmunityBio Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of ImmunityBio's Days Sales Outstanding

For the Biotechnology subindustry, ImmunityBio's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmunityBio's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunityBio's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ImmunityBio's Days Sales Outstanding falls into.

ImmunityBio Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ImmunityBio's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.57	*	365
=	0					/	0.57	*	365
=	0.00

ImmunityBio's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.037	*	365 / 4
=	0					/	0.037	*	365 / 4
=	0.00

ImmunityBio (STU:26CA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

ImmunityBio Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ImmunityBio's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunityBio (STU:26CA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (STU:26CA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IBRX:USA 26CA:Germany

Address

3530 John Hopkins Court, San Diego, CA, USA, 92121

Website

https://www.immunitybio.com

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

ImmunityBio (STU:26CA) Headlines

No Headlines